Chemours Co. Files 2025 Proxy Statement
Ticker: CC · Form: DEF 14A · Filed: 2025-03-20T00:00:00.000Z
Sentiment: neutral
Topics: proxy-statement, governance, shareholder-meeting
TL;DR
Chemours DEF 14A filed: vote on exec pay, directors, and company biz at April 22 meeting.
AI Summary
Chemours Co. filed its definitive proxy statement (DEF 14A) on March 20, 2025, for its annual meeting on April 22, 2025. The filing outlines the company's governance, executive compensation, and proposals to be voted on by shareholders. Key details regarding director nominations, auditor ratification, and other corporate matters are presented.
Why It Matters
This filing provides shareholders with crucial information to make informed voting decisions on company leadership and strategic direction at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a routine proxy filing, providing information to shareholders rather than announcing new material events.
Key Numbers
- 85 — Public Documents (Number of documents included in the filing package)
Key Players & Entities
- Chemours Co. (company) — Registrant and filer of the proxy statement
- March 20, 2025 (date) — Date the DEF 14A was filed
- April 22, 2025 (date) — Date of the shareholder meeting
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or definitive proxy statement, is used by companies to solicit shareholder votes on important corporate matters, such as director elections and executive compensation, ahead of an annual or special meeting.
When is the Chemours Co. shareholder meeting?
The Chemours Co. shareholder meeting is scheduled for April 22, 2025.
What type of information is typically found in a DEF 14A?
A DEF 14A typically includes information on director nominees, executive compensation, auditor ratification, shareholder proposals, and other corporate governance matters.
Who is the filer of this document?
The filer of this document is Chemours Co.
What is the SEC file number for this filing?
The SEC file number for this filing is 001-36794.
From the Filing
0001104659-25-025816.txt : 20250320 0001104659-25-025816.hdr.sgml : 20250320 20250320065314 ACCESSION NUMBER: 0001104659-25-025816 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 85 CONFORMED PERIOD OF REPORT: 20250422 FILED AS OF DATE: 20250320 DATE AS OF CHANGE: 20250320 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 25754445 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 DEF 14A 1 tm252323-10_def14a.htm DEF 14A tm252323-10_nonfiling - none - 28.9688789s TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   ) ​ Filed by the Registrant   ☒ ​ ​ Filed by a Party other than the Registrant   ☐ ​ ​ ​ Check the appropriate box: ​ ​ ​ ​ ☐ ​ ​ ​ Preliminary Proxy Statement ​ ​ ​ ​ ☐ ​ ​ ​ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ​ ​ ​ ​ ☒ ​ ​ ​ Definitive Proxy Statement ​ ​ ​ ​ ☐ ​ ​ ​ Definitive Additional Materials ​ ​ ​ ​ ☐ ​ ​ ​ Soliciting Material under §240.14a-12 ​ ​ THE CHEMOURS COMPANY ​ (Name of Registrant as Specified in its Charter)   ​ (Name of Person(s) Filing Proxy Statement, if other than the Registrant) ​ ​ Payment of Filing Fee (Check the appropriate box): ​ ​ ​ ​ ☒ ​ ​ ​ No fee required. ​ ​ ​ ​ ☐ ​ ​ ​ Fee paid previously with preliminary materials. ​ ​ ​ ​ ☐ ​ ​ ​ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11 ​ ​   TABLE OF CONTENTS TABLE OF CONTENTS ​ March 20, 2025 ​ ​ 1007 Market Street Wilmington, Delaware 19801 ​ ​ ​ ​ DAWN FARRELL CHAIR OF THE BOARD ​ DEAR FELLOW SHAREHOLDERS: On behalf of the Board of Directors, thank you for your continued trust and investment in Chemours. As a company, we take immense pride in using our deep expertise in chemistry to continuously innovate and deliver mission-critical solutions that are enabling and shaping the future. In 2024, our refreshed business strategy reinvigorated our work to deliver trusted chemistry, make people’s lives better, and help our communities thrive, providing a solid foundation to create sustained value for our shareholders. NEW LEADERSHIP TEAM AND STRATEGY FOR LONG TERM SUCCESS With a refreshed leadership team and driven by consistent and effective operational execution, we were pleased to deliver solid financial results in 2024 that demonstrate our positive momentum. We remain confident that our continued focus will drive strong operational and financial performance across our three businesses, and ultimately position Chemours on a pathway to success. Denise Dignam was appointed CEO in March 2024. She is an experienced and capable executive with over 35 years of experience in the chemical industry and a proven track record of results in